CAS 82857-39-4

ATOMOXETINE IMPURITY B CRS

CAS : 82857-39-4

ATOMOXETINE IMPURITY B CRS

Formule : C₁₇H₂₁NO

Masse moléculaire : 255.3547

Ref: 41-Y0001588

Atomoxetine S-Isomer ((S)-N-Methyl-3-phenyl-3-(2-tolyloxy)propan-1-amine hydrochloride)

CAS : 82857-39-4

Amino-alcohols, other than those containing more than o

Formule : C₁₇H₂₁NO·HCl

Couleur et forme : White Powder

Masse moléculaire : 255.16231

Ref: 45-1044913

1H,2H,3H,4H,9H-pyrido[3,4-b]indole-1,3-dicarboxylic acid

CAS : 82857-39-4

1H,2H,3H,4H,9H-pyrido[3,4-b]indole-1,3-dicarboxylic acid

Degré de pureté : ≥98%

Masse moléculaire : 260.25g/mol

Ref: 54-BUP20331

Atomoxetine EP Impurity B HCl ((S)-Atomoxetine HCl)

CAS : 82857-39-4

Formule : C₁₇H₂₁NO·HCl

Masse moléculaire : 255.36 36.46

Ref: 4Z-A-2512

Atomoxetine EP Impurity B

CAS : 82857-39-4

Formule : C₁₇H₂₁NOHCl

Masse moléculaire : 255.4 : 36.46

Ref: ST-EA-CP-A30002

(+)-Tomoxetine hydrochloride

CAS : 82857-39-4

(+)-Tomoxetine hydrochloride is a bioactive chemical.

Formule : C₁₇H₂₂ClNO

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 291.82

Ref: TM-T21028

S-(+)-Atomoxetine Hydrochloride

Produit contrôlé

CAS : 82857-39-4

Impurity Atomoxetine EP Impurity B
Applications ent S-(+)-Atomoxetine Hydrochloride (Atomoxetine EP Impurity B) is an enatiomer of Atomoxetine, a Norepinephrine uptake blocker.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Robertson, D., et al.: J. Med. Chem., 31, 1412 (1988), Hwamg, et al.: Neurosci. Lett., 265, 151 (1999),

Formule : C₁₇H₂₁NO·ClH

Couleur et forme : Neat

Masse moléculaire : 291.82

Ref: TR-A791405

ent S-(+)-atomoxetine hydrochloride

Produit contrôlé

CAS : 82857-39-4

Ent S-Atomoxetine hydrochloride is a drug substance that is used for the preparation of atomoxetine hydrochloride. It is transferred to a suitable container, where it is validated with spectrophotometric measurements. The solution is then diluted and filtered using a phenomenex c18 column. The sample preparation involves the use of rp-hplc and photolytic methods, which can be scaled up to meet the needs of commercial production. Stability tests are performed on the drug substance before diluting it with a suitable solvent for storage, as well as in diluents for intravenous injection. Environment testing may also be required, depending on the formulation type. End>

Formule : C₁₇H₂₂ClNO

Degré de pureté : Min. 95%

Masse moléculaire : 291.82 g/mol

Ref: 3D-FE22676